News in Brief

EC lower minimum protein content for follow-on formula

By Will Chu

- Last updated on GMT

©iStock/
©iStock/
The European Commission has updated legislation concerning food for infants and young children, by ruling that the minimum protein content for follow-on formula be lowered to 1.6 g/100 kcal.

The decision​ follows conclusions made by the European Food Safety Authority (EFSA), which ruled that “Follow-on formula, based on intact protein from cow's milk or from goat's milk, with a protein content of 1.6 g/100 kcal (0,38 g/100 kJ) is safe and suitable for healthy infants living in Europe with an intake of complementary foods of a sufficient quality,”​ back in May 2017.

The Commission’s changes slightly revise values outlined in Regulation (EU) 2016/127, which instructed follow-on formula to contain at least 1.8 g protein/100 kcal (0.43 g/100 kJ).

The maximum value has also been revised with the commission setting out a protein content value of 2.5 g/100 kcal (0.6 g/100 kJ).

EFSA review

The application​for placing a follow‐on formula that satisfied this new minimum onto the market was submitted by Nestlé Nutrition in April 2016.

In the assessment, EFSA looked at the dietary protein requirements of infants aged six to 12 months of age.

Also taken into consideration was the protein content of breast milk during the first year of lactation, as was the protein intake noted in a dietary survey in healthy European infants and two specialised studies.

EFSA’s also considered follow-on formula containing protein from other sources than cow or goat’s milk.

However, the available data did not permit EFSA to conclude the safety and suitability aspects of follow-on formula with a similar protein content consisting of soy protein isolates or protein hydrolysates.

Related news

Show more

Related products

show more

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Has your supplement reached its full potential?

Has your supplement reached its full potential?

Content provided by Rousselot | 04-Apr-2024 | Infographic

In today's wellness-driven market, meet consumer demands with Peptan!
Rousselot's bioactive collagen peptide brand Peptan offers a holistic...

Related suppliers

Follow us

Products

View more

Webinars